COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year

{
  "form": "Dispersion for injection",
  "routes": null,
  "source": "hpra",
  "atc_all": [
    "J07BN01"
  ],
  "strength": null,
  "pa_number": "EU/1/20/1528/037-038",
  "substances": [
    "COVID-19 mRNA vaccine (nucleoside-modified)"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "21/12/2020",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}